DNA repair is activated in early stages of p53-induced apoptosis

Cell Death and Differentiation

Volumn 7, Issue 4, 2000, Pages 393-401

  Geske, F J ^a   Nelson, A C ^a   Lieberman, R ^a   Strange, R ^a   Sun, T ^a,b   Gerschenson, L E ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; DNA repair; p53

Indexed keywords

PROTEIN P21; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CELL CULTURE; CELL CYCLE G1 PHASE; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA REPAIR; MOUSE; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY;

ANIMALIA; MURINAE;

EID: 0034128509     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400663     Document Type: Article

References (57)

1. Soini Y, Paakko P and Lehto V-P (1998) Histopathological evaluation of apoptosis in cancer. Am. J. Pathol. 153: 1041-1053
2. Barnes DM and Camplejohn RS (1996) p53, apoptosis, and breast cancer. J. Mamm. Gland. Biol. Neopl. 1: 163-175
3. White E (1996) Life, death, and the pursuit of apoptosis. Genes Dev. 10: 1-15
4. Hansen R and Oren M (1997) p53; from inductive signal to cellular effect. Curr. Opin. Gene. Dev. 7: 46-51
5. Chen X, Ko LJ, Jayaraman L and Prives C (1996) p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10: 2438-2451
6. Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991) p53 mutations in human cancers. Science 253: 49-53
7. Greenblatt MS, Bennett WP, Hollstein M and Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54: 4855-4878
8. Ko LJ and Prives C (1996) p53: puzzle and paradigm. Genes Dev. 10: 1054-1072
9. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825
10. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ (1993)The p21 cdk-interacting protein Cip 1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816
11. Smith ML and Fornace Jr AJ (1996) The two faces of tumor suppressor p53. Am. J. Pathol. 148: 1019-1022
12. Sanchez Y and Elledge SJ (1995) Stopped for repairs. BioEssays 17: 545-548
13. Smith ML, Chen I-T, Zhan Q, Bae I, Chen C-Y, GilmerTM, Kastan MB, O'Connor PM and Fornace Jr AJ (1994) Interaction of the p53-regulated protein Gadd45 with Proliferating Cell Nuclear Antigen. Science 266: 1376-1380
14. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu J-R and Harris CC (1994) Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. USA 91: 2230-2234
15. Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly J-M, Wang Z, Friedberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K and Harris CC (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet. 10: 188-195
16. Jayaraman L and Prives C (1995) Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81: 1021-1029
17. Lee S, Elenbass B, Levine A and Griffith J (1995) p53 and its 14kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81: 1013-1020
18. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805
19. Adams JM and Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326
20. Canman CE, Gilmer TM, Courts SB and Kastan MB (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9: 600-611
21. Israeli D, Tessler E, Haupt Y, Elkeles A, Wilder S, Amson R, Telerman A and Oren M (1997) A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J. 16: 4384-4392
22. Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389: 300-305
23. Wu GS, BurnsTF, McDonald ERI, Jiang W, Meng R, Krantz ID, Kao G, Gan D-D, Zhou J-Y, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G and El-Deiry WS (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17: 141-143
24. Wang XW, Vermeulen W, Coursen JD, Gibson M, Lupold SE, Forrester K, Xu G, Elmore L, Yeh H, Hoeijmakers JHJ and Harris CC (1996) The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev. 10: 1219-1232
25. Medina D, Oborn CJ, Kittrell FS and Ullrich RL (1986) Properties of mouse mammary epithelial cell lines characterized by in vivo transplantation and in vitro immunocytochemical methods. J. Natl. Cancer Inst. 76: 1143-1151
26. Kaeck M, Lu J, Strange R, Ip C, Ganther HE and Thompson HJ (1997) Differential induction of growth arrest inducible genes by selenium compounds. Biochem. Pharm. 53: 921-926
27. Michalovitz D, Halevy O and Oren M (1990) Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62: 671-680
28. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331
29. Wood RD, Robins P and Lindahl T (1988) Complementation of the Xeroderma Pigmentosum DNA repair defect in cell-free extracts. Cell 53: 97-106
30. Zlatanova J, Yaneva J and Leuba SH (1998) Proteins that specifically recognize cisplatin-damaged DNA: a clue to anticancer activity of cisplatin. FASEB J. 12: 791-799
31. Thornberry NA and Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312-1316
32. Cryns V and Yuan J (1998) Proteases to die for, Genes Dev. 12: 1551-1570
33. Ding H-F, McGill G, Rowan S, Schmaltz C, Shimamura A and Fisher DE (1998) Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system. J. Biol. Chem. 273: 28378-28383
34. Kagawa S, Fujiwara T, Hizuta A, Yasuda T, Zhang WW, Roth JA and Tanaka N (1997) p53 expression overcomes p21/WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells. Oncogene 15: 1903-1909
35. Geske FJ, Lieberman R, Strange R and Gerschenson LE (1995) Evidence for DNA repair in cycloheximide-induced apoptosis using human and mouse cell lines. FASEB J. 9: A419
36. Ford JM and Hanawalt PC (1995) Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl. Acad. Sci. USA 92: 8876-8880
37. Ford JM and Hanawalt PC (1997) Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J. Biol. Chem. 272: 28073-28080
38. Kumar S and Colussi PA (1999) Prodomains-adaptors-oligomerization: the pursuit of caspase activation in apoptosis. Trends Biochem. Sci. 24: 1-4
39. Aravind L, Dixit VM and Koonin EV (1999) The domains of death: evolution cf the apoptosis machinery. Trends Biochem. Sci. 24: 47-53
40. Kroemer G, Zamzami N and Susin SA (1997) Mitochondrial control of apoptosis. Immunol. Today 18:44-51
41. Smith ML and Fornace Jr AJ (1997) p53-mediated protective responses to UV irradiation. Proc. Natl. Acad. Sci. USA 94: 12255-12257
42. McKay BC, Francis MA and Rainbow AJ (1997) Wildtype p53 is required for heat shock and ultraviolet light enhancd repair of a UV-damaged reporter gene. Carcinogenesis 18: 245-249
43. Smith ML, Chen I-T, Zhan Q, O'Connor PM and Fornance Jr AJ (1995) Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 10:1053-1059
44. Sancar A (1995) DNA repair in humans. Ann. Rev. Gen. 29: 69-105
45. Green D and Kroemer G (1998) The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 8: 267-271
46. Janicke RU, Sprengart ML, Wati MR and Porter AG (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273: 9357-9360
47. Sun X-M, MacFarlane M, Zhuang J, Wolf BB, Green DR and Cohen GM (1999) Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274, 5053-5060
48. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK and Rosen A (1996) Apopain/CPP32 cleaves proteins thai are essential for cellular repair: a fundamental principle of apoptotic death. J Exp. Med. 183: 1957-1964
49. Jackson SP and Jeggo PA (1995) DNA double-strand break repair and V(D)J recombination: involvement of DNA-PK. Trends Biochem. Sci. 20: 412-415
50. Jeggo PA, Taccioli GE and Jackson SP (1995) Menage a trois: double strand break repair, V(D)J recombination and DNA-PK. BioEssays 17: 949-957
51. Song Q, Lees-Miller SP, Kumar S, Zhang N, Chan DW, Smith GCM, Jackson SP, Alnemri ES, Litwack G, Khanna KK and Lavin MF (1996) DNA-dependentprotein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J. 15: 3238-3246
52. Stroh C and Schulze-Osthoff K (1998) Death by a thousand cuts: an ever increasing list of caspase substrates. Cell Death Differ. 5: 997-1000
53. Friedberg EC, Walker GC and Siede W (1995) Mutagenesis in prokaryotes. In DNA repair and mutagenesis. (Washington, D.C.: ASM Pressi pp. 465-522
54. Leveillard T, Andera L, Bissonnette N, Schaeffer L, Bracco L, Egly J-M and Wasylyk B (1996) Functional interactions between p53 and fre TFIIH complex are affected by tumour-associated mutations. EMBO J. 15: 1615-1624
55. Harvey KJ, Blomquist JF and Ucker DS (1998) Commitment and effector phases of the physiological cell death pathway elucidated with respect to bcl-2, caspase, and cyclin-dependent kinase activities. Mol. Cell. Biol. 18: 2912-2922
56. Fadok VA, Bratton DL, Frasch SC, Warner ML and Henson PM (1998) The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 5: 551-562
57. Steller H (1995) Mechanisms and genes of cellular suicide. Science 267: 1445-1449